首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA)
Authors:Chung Da-Eun  Kratz Felix
Institution:Tumor Biology Center, Breisacher Strasse 117, 79106 Freiburg, Germany.
Abstract:A water-soluble albumin-binding prodrug of doxorubicin EMC-Gly-Gly-Gly-Arg-Arg-DOXO (EMC, 6-maleimidocaproic acid)] was developed that is cleaved specifically by the tumor-associated protease urokinase-type plasminogen activator (uPA).
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号